HIDRADENITIS SUPPURATIVA

This study tested a new drug, SAR442970, in 86 adults with moderate to severe hidradenitis suppurativa (HS), a chronic skin condition causing painful lumps. The goal was to see if the drug reduces skin inflammation better than a placebo. Participants received either the drug or a…

This study tested a drug called bimekizumab in 505 adults with moderate to severe hidradenitis suppurativa, a chronic skin disease that causes painful boils. The goal was to see if the drug could reduce skin lesions by at least 50% after 16 weeks compared to a placebo. The trial …

This study tested a drug called imsidolimab (ANB019) in 149 adults with hidradenitis suppurativa, a chronic skin condition that causes painful boils and abscesses. Participants received either the drug or a placebo for 16 weeks. The main goal was to see if the drug reduced the nu…

This study tested a drug called bimekizumab in 509 adults with moderate to severe hidradenitis suppurativa, a chronic skin condition that causes painful lumps. The goal was to see if the drug could reduce the number of inflamed bumps and tunnels by at least 50% after 16 weeks com…

This study tested whether tofacitinib, a drug already approved for other conditions, is safe and helpful for people with Down syndrome who also have immune-related skin problems like eczema, psoriasis, or hair loss. The study included 47 adolescents and adults. Researchers measur…

This study looked at the long-term safety and effectiveness of the drug spesolimab for adults with hidradenitis suppurativa (HS), a painful skin condition. Participants who had already completed a previous spesolimab trial received injections every two weeks for two years. The go…

This study tested a medicine called spesolimab in 209 adults with moderate to severe hidradenitis suppurativa (HS), a chronic skin condition causing painful lumps. Participants received either spesolimab or a placebo for about a year. The goal was to see if spesolimab reduces dra…

This study looked at whether switching from a lower to a higher concentration of adalimumab (AVT-02) reduces injection site pain and improves treatment adherence. It involved 324 adults with conditions like Crohn's disease, rheumatoid arthritis, or psoriasis. Researchers measured…

This study looked at whether mindfulness training can help people with hidradenitis suppurativa (HS) feel better about their quality of life. HS is a painful skin condition that can deeply affect daily life. Researchers enrolled 37 adults with HS and measured changes in their qua…

This study tested an investigational drug called AVTX-009 against a placebo in 253 people with moderate to severe hidradenitis suppurativa (HS), a chronic skin condition causing painful boils and tunnels. The main goal was to see if the drug could reduce skin lesions by at least …

This study tested a medicine called spesolimab in 52 adults with moderate to severe hidradenitis suppurativa, a chronic skin condition causing painful lumps and boils. Participants received either spesolimab or a placebo for about 3 months. Doctors counted skin lesions to see if …

This study tested whether a special bioelectric dressing can improve healing after a surgical procedure called de-roofing for hidradenitis suppurativa (HS). Twelve adults with HS took part. The dressing was applied to wounds after surgery, and researchers measured how fast the wo…

This study tested an experimental drug called ATI-450 in 95 people with moderate to severe hidradenitis suppurativa (HS), a painful skin condition that causes boils and abscesses. Participants received either ATI-450 or a placebo for 12 weeks. The main goal was to see if the drug…

This study looked at skin samples from 20 people with hidradenitis suppurativa (HS) to understand what causes inflammation in the disease. Researchers measured various inflammatory proteins in the skin to see which ones might be driving the condition. The goal was to learn more a…

This study involved 67 adults with hidradenitis suppurativa, a painful skin condition. Researchers used surveys and photos to learn how the disease impacts quality of life and to test a tool that lets patients rate their own disease severity. The goal was to better understand the…